Patents by Inventor Patrick Branigan

Patrick Branigan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Safe and effective method of treating psoriasis with anti-IL-23 specific antibody
    Patent number: 11548941
    Abstract: A method of treating psoriasis in a patient by administering an IL-23 specific antibody, e.g., guselkumab, in a clinically proven safe and clinically proven effective amount and the patient achieves PASI90, PASI100 or IGA 0 or 1 score as measured 16, 24, 32, 40 and 48 weeks after initial treatment and the patient achieves higher efficacy than a patient treated with the secukinumab antibody.
    Type: Grant
    Filed: November 19, 2019
    Date of Patent: January 10, 2023
    Assignee: JANSSEN BIOTECH, INC.
    Inventors: Julianty Angsana, Patrick Branigan, Samuel DePrimo, Susan Flavin, Shu Li, Xuejun Liu, Ernesto Munoz, Bruce Randazzo
  • SAFE AND EFFECTIVE METHOD OF TREATING PSORIASIS WITH ANTI-IL-23 SPECIFIC ANTIBODY
    Publication number: 20220289835
    Abstract: A method of treating psoriasis in a patient by administering an IL-23 specific antibody, e.g., guselkumab, in a clinically proven safe and clinically proven effective amount and the patient achieves PASI90, PASI100 or IGA 0 or 1 score as measured 16, 24, 32, 40 and 48 weeks after initial treatment and the patient achieves higher efficacy than a patient treated with the secukinumab antibody.
    Type: Application
    Filed: May 2, 2022
    Publication date: September 15, 2022
    Inventors: Julianty Angsana, Patrick Branigan, Samuel DePrimo, Susan Flavin, Shu Li, Xeujun Liu, Ernesto Munoz, Bruce Randazzo
  • Safe and Effective Method of Treating Psoriasis with Anti-IL-23 Specific Antibody
    Publication number: 20200157209
    Abstract: A method of treating psoriasis in a patient by administering an IL-23 specific antibody, e.g.
    Type: Application
    Filed: November 19, 2019
    Publication date: May 21, 2020
    Inventors: Julianty Angsana, Patrick Branigan, Samuel DePrimo, Susan Flavin, Shu Li, Xuejun Liu, Ernesto Munoz, Bruce Randazzo
  • Humanized IL-25 antibodies
    Patent number: 8785605
    Abstract: The present invention relates to target binding members (e.g., antibodies) that bind a specified epitope of human IL-25. The invention also relates to target binding members (e.g., antibodies) that comprise one or more humanized antibody VL domain sequences and bind IL-25. The invention further relates to compositions comprising target binding members (e.g., antibodies) that bind IL-25, methods of producing such target binding members, and uses of such target binding members for the treatment or prevention of diseases and conditions (e.g., asthma, inflammatory bowel disease).
    Type: Grant
    Filed: March 30, 2011
    Date of Patent: July 22, 2014
    Assignee: Janssen Biotech, Inc.
    Inventors: Juan Carlos Almagro, Patrick Branigan, Colleen Kane, William Strohl, Susann Taudte, Mark Tornetta, John Wheeler
  • Methods for mediating fibrotic response
    Patent number: 8574582
    Abstract: Methods for mediating fibrotic response by modulating IL-25 signaling in fibrocytes are disclosed.
    Type: Grant
    Filed: October 27, 2009
    Date of Patent: November 5, 2013
    Assignee: Janssen Biotech, Inc.
    Inventors: Patrick Branigan, Jason Ekert
  • Humanized IL-25 Antibodies
    Publication number: 20110318353
    Abstract: The present invention relates to target binding members (e.g., antibodies) that bind a specified epitope of human IL-25. The invention also relates to target binding members (e.g., antibodies) that comprise one or more humanized antibody VL domain sequences and bind IL-25. The invention further relates to compositions comprising target binding members (e.g., antibodies) that bind IL-25, methods of producing such target binding members, and uses of such target binding members for the treatment or prevention of diseases and conditions (e.g., asthma, inflammatory bowel disease).
    Type: Application
    Filed: March 30, 2011
    Publication date: December 29, 2011
    Inventors: Juan Carlos Almagro, Patrick Branigan, Colleen Kane, William Strohl, Susann Taudte, Mark Tornetta, John Wheeler
  • Anti-Respiratory Syncytial Virus Antibodies, Antigens and Uses Thereof
    Publication number: 20110027294
    Abstract: Anti-Respiratory Syncytial Virus (RSV) monoclonal antibodies, RSV F protein antigens and their uses are disclosed.
    Type: Application
    Filed: October 8, 2010
    Publication date: February 3, 2011
    Inventors: Alfred Delvecchio, Ping Tsui, Patrick Branigan, Leslee Conrad, Nicole Day, Changbao Liu, Raymond Sweet, Sheng-Jiun Wu, Jose Melero, Jinquan Luo, Gabriela Canziani, Mark Tornetta, Gopalan Raghunathan, Venkata Chalapathi Koka
  • Methods for Mediating Fibrotic Response
    Publication number: 20100111968
    Abstract: Methods for mediating fibrotic response by modulating IL-25 signaling in fibrocytes are disclosed.
    Type: Application
    Filed: October 27, 2009
    Publication date: May 6, 2010
    Inventors: Patrick Branigan, Jason Ekert
  • Method for generating monoclonal antibodies
    Publication number: 20060246061
    Abstract: Methods for generating monoclonal antibodies in Th1-biased rodents are disclosed. The monoclonal antibodies are useful as therapeutic agents, diagnostic agents or research reagents.
    Type: Application
    Filed: June 28, 2006
    Publication date: November 2, 2006
    Inventors: M. MBow, Patrick Branigan, Jill Giles-Komar, Linda Snyder, George Heavner
  • Anti-respiratory syncytial virus antibodies, antigens and uses thereof
    Publication number: 20060159695
    Abstract: Anti-Respiratory Syncytial Virus (RSV) monoclonal antibodies, RSV F protein antigens and their uses are disclosed.
    Type: Application
    Filed: October 28, 2005
    Publication date: July 20, 2006
    Inventors: Alfred Delvecchio, Ping Tsui, Patrick Branigan, Leslee Conrad, Nicole Day, Changbao Liu, Raymond Sweet, Sheng-Jiun Wu, Jose Melero, Jinquan Luo, Gabriela Canziani, Mark Tornetta, Gopalan Raghunathan, Venkata Koka
  • Nucleic acid compositions and methods for use
    Publication number: 20050261213
    Abstract: Polynucleotide compositions encoding a tumor antigen antigenic determinant and optionally including a nucleic acid adjuvant are disclosed. The compositions are useful for prophylaxis or treatment of cancer.
    Type: Application
    Filed: March 28, 2003
    Publication date: November 24, 2005
    Inventors: Patrick Branigan, Theresa Goletz, David Knight, Stephen McCarthy, Bernard Scallon, Linda Snyder
  • Method for generating monoclonal antibodies
    Publication number: 20030235891
    Abstract: Methods for generating monoclonal antibodies in Th1-biased rodents are disclosed. The monoclonal antibodies are useful as therapeutic agents, diagnostic agents or research reagents.
    Type: Application
    Filed: June 20, 2003
    Publication date: December 25, 2003
    Inventors: M. Lamine MBow, Patrick Branigan, Jill Giles-Komar, Linda Snyder, George Heavner